Anti-Parietal Antibody
APCA, Anti-Parietal Cell Antibody, Anti Parietal Cell Antibody
Test Codes
EPIC: LAB1231599, SOFT: APA
Department
Immunology
Specimen Collection Criteria
Collect: One Gold-top SST tube. (Minimum Whole Blood: 2.0 mL)
Physician Office/Draw Specimen Preparation
Let specimen clot 30-60 minutes then immediately centrifuge to separate serum from cells. Refrigerate (2-8°C or 36-46°F) the centrifuged collection tube within two hours of collection. (Minimum Serum: 0.5 mL)
Preparation for Courier Transport
Transport: Centrifuged collection tube, refrigerated (2-8 °C or 36-46 °F). (Minimum Serum: 0.5 mL)
Rejection Criteria
Plasma specimens.
Severely lipemic, icteric or hemolyzed specimens.
In-Lab Processing
Let specimen clot 30-60 minutes then immediately centrifuge to separate serum from cells. Room temperature is acceptable for a maximum of two hours. (Minimum Serum: 0.5 mL)
Storage
Specimen Stability for Testing:
Centrifuged SST Tubes and Microtainers® with Separator Gels
Room Temperature (20-26°C or 68-78.8°F): 2 hours
Refrigerated (2-8°C or 36-46°F): 72 hours
Frozen (-20°C/-4°F or below): Unacceptable
Red-top Tubes and Microtainers® without Separator Gels
Room Temperature (20-26°C or 68-78.8°F): 2 hours
Refrigerated (2-8°C or 36-46°F): Unacceptable
Frozen (-20°C/-4°F or below): Unacceptable
Serum Specimens (Pour-Overs)
Room Temperature (20-26°C or 68-78.8°F): 2 hours
Refrigerated (2-8°C or 36-46°F): 72 hours
Frozen (-20°C/-4°F or below): 3 months
Specimen Storage in Department Prior to Disposal:
Refrigerated (2-8°C or 36-46°F): 7 days
Laboratory
Royal Oak Special Chemistry Laboratory
Performed
Monday, Wednesday, Friday.
Results available within 2 business days.
Reference Range
Less than 1:20.
Test Methodology
Indirect Immunofluorescent Assay (IFA).
Interpretation
- Anti-Parietal Cell antibody (APCA) occurs in 90% of patients with pernicious anemia. Other disorders which may have APCA include gastric ulcer, atrophic gastritis, thyroid disease, diabetes mellitus and iron deficiency anemia. APCA occurs in less than 2% of the normal population under 20 years; however, the incidence of APCA increases in women over the age of 40 and may be present in up to 16% of the normal population over 60 years of age.
- Most patients with pernicious anemia have parietal cell antibodies. However, the fact that such antibodies are found with increased frequency in unaffected family members, as well as in patients with other autoimmune diseases, suggest these antibodies do not cause disease by themselves. This assay is for use as a diagnostic aid only.
- Low titer positive results may occur in healthy individuals. The results of this assay must be interpreted in regard to the patient's total clinical presentation.
Clinical Utility
The Anti-Parietal Cell antibody (APCA) assay along with other clinical and laboratory data helps to distinguish autoimmune pernicious anemia from other megaloblastic anemias.
CPT Codes
86256
LOINC: 5271-2
Contacts
Special Chemistry Laboratory – RO
248-551-8071
Name: Special Chemistry Laboratory – RO
Location:
Phone: 248-551-8071
Last Updated
7/21/2024
Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.